Serum albumin levels measured during the hospital stay for induction chemotherapy of AML patients with FO were similar to those of AML patients without FO (3.3 g/dl, range 2.1–3.8 vs. 3.4 g/dl, range 2.25–4.2, p=0.117). The gene discussed is ALB; the disease is acute myeloid leukemia.